Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation

Current Opinion in Immunology

Volumn 16, Issue 5, 2004, Pages 634-643

  Dupont, Bo ^a   Hsu, Katharine C ^a  

^a Depts of Medicine and Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; HLA ANTIGEN CLASS 1; LIGAND;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL ACTIVATION; DONOR; ETHNIC DIFFERENCE; GENE; GENE CLUSTER; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOBIOLOGY; IMMUNOGENETICS; IMMUNOREACTIVITY; INHIBITION KINETICS; MALIGNANT NEOPLASTIC DISEASE; MODEL; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NONHUMAN; PATIENT; PROTEIN ANALYSIS; RECIPIENT; REVIEW; TUMOR IMMUNITY;

ANIMALS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; PHYLOGENY; RECEPTORS, IMMUNOLOGIC;

EID: 4444307713     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.07.013     Document Type: Review

References (57)

1. G. Cudkowicz, and M. Bennett Peculiar immunobiology of bone marrow allografts. I. Graft rejection by heavily irradiated "responder" mice J Exp Med 134 1971 83 102
2. G. Cudkowicz, and M. Bennett Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by F1 hybrid mice J Exp Med 134 1971 1513 1528
3. P. Parham, and K.L. McQueen Alloreactive killer cells: hindrance and help for haematopoietic transplants Nat Rev Immunol 3 2003 108 122
4. I. Barao, and W.J. Murphy The immunobiology of natural killer cells and bone marrow allograft rejection Biol Blood Marrow Transplant 9 2003 727 741
5. L. Ruggeri, M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R.S. Negrin, M.F. Martelli, and A. Velardi Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation Blood 94 1999 333 339
6. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, and F. Aversa Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
7. H.G. Ljunggren, and K. Karre In search of the "missing self": MHC molecules and NK cell recognition Immunol Today 11 1990 237 244
8. S.M. Davies, L. Ruggeri, T. DeFor, J.E. Wagner, D.J. Weisdorf, J.S. Miller, A. Velardi, and B.R. Blazar Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor Blood 100 2002 3825 3827
9. M. Bornhauser, R. Schwerdtfeger, H. Martin, K.H. Frank, C. Theuser, and G. Ehninger Letter to editor: Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors Blood 103 2004 2860 2861
10. S. Giebel, F. Locatelli, T. Lamparelli, A. Velardi, S. Davies, G. Frumento, R. Maccario, F. Bonetti, J. Wojnar, and M. Martinetti Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 2003 814 819
11. J. Trowsdale, R. Barten, A. Haude, C.A. Stewart, S. Beck, and M.J. Wilson The genomic context of natural killer receptor extended gene families Immunol Rev 181 2001 20 38
12. M. Kasahara The chromosomal duplication model of the major histocompatibility complex Immunol Rev 167 1999 17 32
13. J.K. Kulski, T. Shiina, T. Anzai, S. Kohara, and H. Inoko Comparative genomic analysis of the MHC: the evolution of class I duplication blocks, diversity and complexity from shark to man Immunol Rev 190 2002 95 122
14. S.J. Strong, M.G. Mueller, R.T. Liman, N.A. Hawke, R.N. Haire, A.L. Miracle, J.P. Rast, C.T. Amemiya, and G.W. Litman A novel multigene family encodes diversified variable regions Proc Natl Acad Sci USA 96 1999 15080 15085
15. N.A. Hawke, J.A. Yoder, R.N. Haire, M.G. Mueller, R.T. Litman, A.L. Miracle, T. Stuge, L. Shen, N. Miller, and G.W. Litman Extraordinary variation in a diversified family of immune-type receptor genes Proc Natl Acad Sci USA 98 2001 13832 13837
16. J.A. Yoder, M.G. Mueller, S. Wei, B.C. Corliss, D.M. Prather, T. Willis, R.T. Litman, J.Y. Djeu, and G.W. Litman Immune-type receptor genes in zebrafish share genetic and functional properties with genes encoded by mammalian leukocyte receptor cluster Proc Natl Acad Sci USA 98 2001 6771 6776
17. J.P. Cannon, R.N. Haire, and G.W. Litman Identification of diversified genes that contain immunoglobulin-like variable regions in a protochordate Nat Immunol 3 2002 1200 1207
18. J. Kaufman The origins of the adaptive immune system: whatever next? Nat Immunol 3 2002 1124 1125
19. K. Khalturin, M. Becker, B. Rinkevich, and T.C. Bosch Urochordates and the origin of natural killer cells: identification of a CD94/NKR-P1-related receptor in blood cells of Botryllus Proc Natl Acad Sci USA 100 2003 622 627
20. T. Shiina, S. Shimizu, K. Hosomichi, S. Kohara, S. Watanabe, K. Hanzawa, S. Beck, J.K. Kulski, and H. Inoko Comparative genomic analysis of two avian (quail and chicken) MHC regions J Immunol 172 2004 6751 6763 This paper demonstrates the fifth MHC paralogous linkage group of C-type lectin receptors to human chromosome 12p12-13.
21. C. Vilches, and P. Parham KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217 251
22. M. Colonna, F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells J Exp Med 186 1997 1809 1818
23. J. Dietrich, M. Cella, and M. Colonna Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization J Immunol 166 2001 2514 2521
24. M. Shiroishi, K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V.M. Braud, Allan DSJ, A. Makadzange, S. Rowland-Jones, and B. Willcox Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G Proc Natl Acad Sci USA 100 2003 8856 8861 This paper provides detailed data on HLA class I alleles binding to ILT2 and ILT4.
25. Carrington M, Norman P: The KIR gene cluster. 2003, http://www.ncbi.nlm. nih.gov:80/books.
26. K.C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R.J. O'Reilly, and B. Dupont Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets J Immunol 169 2002 5118 5129
27. K.C. Hsu, S. Chida, D.E. Geraghty, and B. Dupont The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism Immunol Rev 190 2002 40 52
28. GenBank on World Wide Web URL: http://www.ncbi.nlm.nih.gov/Genbank/index. html (Accession number AY320039). This website provides complete nucleotide sequence data and gene order for the 'long' KIR-B haplotype. The centromeric location of 2DS2 next to 2DL2 is documented. Together with the genomic analysis reported in [30] these studies provide the genomic information that led to the current model for the organisation of the KIR genomic region illustrated in Figure 3 and reported in [27].
29. M.P. Martin, A. Bashirova, J. Traherne, J. Trowsdale, and M. Carrington Cutting edge: expansion of the KIR locus by unequal crossing over J Immunol 171 2003 2192 2195
30. M.J. Wilson, M. Tokar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale Plasticity in the organization and sequences of human KIR/ILT gene families Proc Natl Acad Sci USA 97 2000 4778 4783
31. M. Yawata, N. Yawata, K.L. McQueen, N.W. Cheng, L.A. Guethlein, R. Rajalingam, H.G. Shilling, and P. Parham Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression Immunogenetics 54 2002 543 550
32. H.G. Shilling, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, R. Rodriguez, D. Tyan, and P. Parham Allelic polymorphism synergies with variable gene content to individualize human KIR genotype J Immunol 168 2002 2307 2315
33. M.J. Pando, C.M. Gardiner, M. Gleimer, K.L. McQueen, and P. Parham The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1 J Immunol 171 2003 6640 6649
34. M. Faure, and E.O. Long KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential J Immunol 168 2002 6208 6214
35. C.S. Witt, A. Martin, and F.T. Christiansen Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail Tissue Antigens 56 2000 248 257
36. A. Kikuchi-Maki, S. Yusa, T.L. Catina, and K.S. Campbell KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production J Immunol 171 2003 3415 3425
37. C. Vilches, C.M. Gardiner, and P. Parham Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene J Immunol 165 2000 6416 6421
38. L.D. Maxwell, A. Wallace, D. Middleton, and M.D. Curran A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey Tissue Antigens 60 2002 254 258
39. N.M. Valiante, M. Uhrberg, H.G. Shilling, K. Lienert-Weidenbach, K.L. Arnett, A. D'Andrea, J.H. Phillips, L.L. Lanier, and P. Parham Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors Immunity 7 1997 739 751
40. C. Frohn, P. Schlenke, and H. Kirchner The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes Immunology 92 1997 567 570
41. R. Grau, K.S. Lang, D. Wernet, P. Lang, D. Niethammer, C.M. Pusch, and R. Handgretinger Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals Exp Mol Pathol 76 2004 90 98 This paper provides a detailed analysis of NK cells lacking KIR for 'self' HLA molecules. The authors test the cytolytic potentials of NK clones against autologous CD34 stem cells and describe NK clones with potential autoreactivity.
42. H.G. Shilling, N. Young, L.A. Guethlein, N.W. Cheung, C.M. Gardiner, D. Tyan, and P. Parham Genetic control of human NK cell repertoire J Immunol 169 2002 239 247
43. D.H. Raulet, R.E. Vance, and C.W. McMahon Regulation of the natural killer cell receptor repertoire Annu Rev Immunol 19 2001 291 330
44. H.G. Shilling, K.L. McQueen, N.W. Cheng, J.A. Shizuru, R.S. Negrin, and P. Parham Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood 101 2003 3730 3740
45. W. Leung, R. Iyengar, V. Turner, P. Lang, P. Bader, P. Conn, D. Niethammer, and R. Handgretinger Determinants of antileukemia effects of allogeneic NK cells J Immunol 172 2004 644 650 The first systematic report of outcome of HCT in patients selected for transplantation based on the 'missing KIR ligand' model applied to HLA mismatched donor-recipient pairs. Both KIR and HLA genotyping was applied for defining the two transplant groups. The authors report on transplant outcome and have analysed post-transplantation NK repertoire.
46. W.M. Yokoyama Hybrid resistance and the Ly-49 family of natural killer cell receptors J Exp Med 182 1995 273 277
47. C.Y. Koh, B.R. Blazar, T. George, L.A. Welniak, C.M. Capitini, A. Raziuddin, W.J. Murphy, and M. Bennett Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo Blood 97 2001 3132 3137
48. C.Y. Koh, A. Raziuddin, L.A. Welniak, B.R. Blazar, M. Bennett, and W.J. Murphy NK inhibitory-receptor blockade for purging of leukemia: effects on hematopoietic reconstitution Biol Blood Marrow Transplant 8 2002 17 25
49. C.Y. Koh, J.R. Ortaldo, B.R. Blazar, M. Bennett, and W.J. Murphy NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade Blood 102 2003 4067 4075 This study together with [47,48] describe the use of blocking Ly49 antibodies detecting inhibitory NK receptors. Augmentation of anti-tumour effects of NK cells following antibody purging ex vivo is reported for syngeneic and autologous NK cells.
50. S. Bauer, V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 1999 727 729
51. A. Dienfenbach, E.R. Jensen, A.M. Jamieson, and D.H. Raulet Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity Nature 413 2001 165 171
52. A. Cerwenka, J.L. Baron, and L.L. Lanier Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo Proc Natl Acad Sci USA 98 2001 11521 11526
53. H.R. Salih, H. Antropius, F. Gieseke, S.Z. Lutz, L. Kanz, H.-G. Rammensee, and A. Steinle Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia Blood 102 2003 1389 1396
54. A. Bishara, D. De Santis, C.C. Witt, C. Brautbar, F.T. Christiansen, R. Or, A. Nagler, and S. Slavin The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD Tissue Antigens 63 2004 204 211
55. M.A. Cook, D.W. Milligan, C.D. Fegan, P.J. Darbyshire, P. Mahendra, C.F. Craddock, P.A. Moss, and D.C. Briggs The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia Blood 103 2004 1521 1526
56. L.F. Porrata, D.J. Inwards, I.N. Micallef, S.M. Ansell, S.M. Geyer, and S.N. Markovic Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease Br J Haematol 117 2002 629 633
57. L.F. Porrata, M.R. Litzow, D.J. Inwards, D.A. Gastineau, S.B. Moore, A.A. Pineda, K.L. Bundy, D.J. Padley, D. Persky, and S.M. Ansell Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma Bone Marrow Transplant 33 2004 291 298